Our top pick for
Building a portfolio

Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
iRhythm Technologies, Inc is a medical instruments & supplies business based in the US. iRhythm Technologies shares (IRTC) are listed on the NASDAQ and all prices are listed in US Dollars. iRhythm Technologies employs 1,157 staff and has a trailing 12-month revenue of around USD$265.2 million.
Our top pick for
Building a portfolio
Our top pick for
Beginners
Our top pick for
Active traders
52-week range | USD$78 - USD$286.19 |
---|---|
50-day moving average | USD$142.2497 |
200-day moving average | USD$203.4325 |
Wall St. target price | USD$216 |
PE ratio | N/A |
Dividend yield | N/A (0%) |
Earnings per share (TTM) | USD$-1.823 |
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Revenue TTM | USD$265.2 million |
---|---|
Gross profit TTM | USD$194.9 million |
Return on assets TTM | -6.67% |
Return on equity TTM | -18.38% |
Profit margin | -16.53% |
Book value | $11.772 |
Market capitalisation | USD$3.9 billion |
TTM: trailing 12 months
There are currently 2.8 million iRhythm Technologies shares held short by investors – that's known as iRhythm Technologies's "short interest". This figure is 14.7% down from 3.3 million last month.
There are a few different ways that this level of interest in shorting iRhythm Technologies shares can be evaluated.
iRhythm Technologies's "short interest ratio" (SIR) is the quantity of iRhythm Technologies shares currently shorted divided by the average quantity of iRhythm Technologies shares traded daily (recently around 578505.97938144). iRhythm Technologies's SIR currently stands at 4.85. In other words for every 100,000 iRhythm Technologies shares traded daily on the market, roughly 4850 shares are currently held short.
However iRhythm Technologies's short interest can also be evaluated against the total number of iRhythm Technologies shares, or, against the total number of tradable iRhythm Technologies shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case iRhythm Technologies's short interest could be expressed as 0.1% of the outstanding shares (for every 100,000 iRhythm Technologies shares in existence, roughly 100 shares are currently held short) or 0.1179% of the tradable shares (for every 100,000 tradable iRhythm Technologies shares, roughly 118 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against iRhythm Technologies.
Find out more about how you can short iRhythm Technologies stock.
We're not expecting iRhythm Technologies to pay a dividend over the next 12 months.
Over the last 12 months, iRhythm Technologies's shares have ranged in value from as little as $78 up to $286.19. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while iRhythm Technologies's is 1.6595. This would suggest that iRhythm Technologies's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
iRhythm Technologies, Inc., a digital healthcare company, provides ambulatory electrocardiogram (ECG) monitoring products for patients at risk for arrhythmias in the United States. It offers Zio service, an ambulatory cardiac monitoring solution that combines a wire-free, patch-based, and wearable biosensor with a cloud-based data analytic platform to help physicians to monitor patients and diagnose arrhythmias. The company's Zio XT and AT monitors, a single-use, wire-free, and wearable patch-based biosensors, records patient's heartbeats and ECG data. It has a development collaboration agreement with Verily Life Sciences LLC to develop various next-generation atrial fibrillation screening, detection, or monitoring products. iRhythm Technologies, Inc. was incorporated in 2006 and is headquartered in San Francisco, California.
Steps to owning and managing SGLB, with 24-hour and historical pricing before you buy.
Steps to owning and managing SSD, with 24-hour and historical pricing before you buy.
Steps to owning and managing SQNS, with 24-hour and historical pricing before you buy.
Steps to owning and managing SFL, with 24-hour and historical pricing before you buy.
Steps to owning and managing AIHS, with 24-hour and historical pricing before you buy.
Steps to owning and managing ST, with 24-hour and historical pricing before you buy.
Steps to owning and managing SLCT, with 24-hour and historical pricing before you buy.
Steps to owning and managing EYES, with 24-hour and historical pricing before you buy.
Steps to owning and managing SBSW, with 24-hour and historical pricing before you buy.
Steps to owning and managing SHG, with 24-hour and historical pricing before you buy.